InsideTrading SEC Form 4 insider trades

Stocks

BTAIQ BioXcel Therapeutics, Inc.

Healthcare · Market cap: $372.5K

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $0, sold $0 2022-Q2: bought $0, sold $0 2022-Q3: bought $0, sold $0 2022-Q4: bought $0, sold $2.1M 2023-Q1: bought $0, sold $5.0M 2023-Q2: bought $0, sold $2.6M 2023-Q3: bought $0, sold $0 2023-Q4: bought $0, sold $0 2024-Q1: bought $0, sold $0 2024-Q2: bought $0, sold $434.3K 2024-Q3: bought $0, sold $2.3K 2024-Q4: bought $0, sold $19.9K 2025-Q1: bought $0, sold $0 2025-Q2: bought $0, sold $0 2025-Q3: bought $0, sold $0 2025-Q4: bought $0, sold $0 2026-Q1: bought $0, sold $0 2026-Q2: bought $0, sold $43.2K 2026-Q3: bought $0, sold $0 2026-Q4: bought $0, sold $0
Bought, above the line (largest quarter $0) Sold, below the line (largest quarter $5.0M)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$0$0
2022-Q2$0$0
2022-Q3$0$0
2022-Q4$0$2.1M
2023-Q1$0$5.0M
2023-Q2$0$2.6M
2023-Q3$0$0
2023-Q4$0$0
2024-Q1$0$0
2024-Q2$0$434.3K
2024-Q3$0$2.3K
2024-Q4$0$19.9K
2025-Q1$0$0
2025-Q2$0$0
2025-Q3$0$0
2025-Q4$0$0
2026-Q1$0$0
2026-Q2$0$43.2K
2026-Q3$0$0
2026-Q4$0$0

Insider activity

Download CSV Up to 5,000 rows
Bought$00 buy days
Sold$10.3M54 sell days
Net insider flow-$10.3Mnet selling · 5 years
Latest trade2026-05-20Mehta Vimal
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2026-05-20 Sell Mehta Vimal CEO 19,419 $1.09 $21.2K 1
2026-05-20 Sell Yocca Frank Other C-suite 6,845 $1.09 $7.5K 1
2026-05-20 Sell Steinhart Richard I CFO 6,845 $1.09 $7.5K 1
2026-05-20 Sell Rodriguez Javier Other officer 6,560 $1.08 $7.1K 1
2024-12-16 Sell Mehta Vimal CEO 3,117 $0.36 $1.1K 2
2024-12-16 Sell Steinhart Richard I CFO 577 $0.36 $208 2
2024-12-16 Sell Rodriguez Javier Other officer 430 $0.36 $155 2
2024-12-16 Sell Yocca Frank Other C-suite 430 $0.35 $153 2
2024-12-16 Sell O'Neill Vincent Other officer 165 $0.35 $58 1
2024-10-03 Sell Yocca Frank Other C-suite 7,175 $0.55 $3.9K 1
2024-10-03 Sell Steinhart Richard I CFO 7,175 $0.55 $3.9K 1
2024-10-03 Sell Rodriguez Javier Other officer 6,863 $0.55 $3.8K 1
2024-10-03 Sell Wiley Matthew T. Other C-suite 6,272 $0.55 $3.4K 1
2024-10-03 Sell O'Neill Vincent Other officer 5,556 $0.55 $3.1K 1
2024-09-16 Sell Mehta Vimal CEO 1,982 $0.69 $1.4K 2
2024-09-16 Sell Steinhart Richard I CFO 356 $0.69 $246 1
2024-09-16 Sell Yocca Frank Other C-suite 355 $0.69 $245 1
2024-09-16 Sell Rodriguez Javier Other officer 345 $0.69 $238 1
2024-09-16 Sell Wiley Matthew T. Other C-suite 215 $0.69 $148 1
2024-09-16 Sell O'Neill Vincent Other officer 138 $0.69 $95 1
2024-06-17 Sell Mehta Vimal CEO 2,134 $1.28 $2.7K 1
2024-06-17 Sell Yocca Frank Other C-suite 372 $1.28 $476 1
2024-06-17 Sell Steinhart Richard I CFO 372 $1.26 $469 1
2024-06-17 Sell Rodriguez Javier Other officer 361 $1.26 $455 1
2024-06-17 Sell Wiley Matthew T. Other C-suite 244 $1.26 $307 1
2024-06-17 Sell O'Neill Vincent Other officer 155 $1.29 $200 1
2024-06-05 Sell Mehta Vimal CEO 126,014 $1.58 $199.1K 1
2024-06-04 Sell Mehta Vimal CEO 126,014 $1.63 $205.4K 1
2024-04-04 Sell Mehta Vimal CEO 5,268 $2.62 $13.8K 2
2024-04-04 Sell Steinhart Richard I CFO 1,069 $2.64 $2.8K 1
2024-04-04 Sell Yocca Frank Other C-suite 1,067 $2.64 $2.8K 1
2024-04-04 Sell Rodriguez Javier Other officer 1,012 $2.64 $2.7K 1
2024-04-04 Sell Wiley Matthew T. Other C-suite 1,008 $2.64 $2.7K 1
2024-04-04 Sell O'Neill Vincent Other officer 165 $2.62 $432 1
2023-06-16 Sell Mehta Vimal CEO 30,000 $20.18 $605.5K 3
2023-06-15 Sell Mehta Vimal CEO 30,000 $21.54 $646.2K 2
2023-05-22 Sell Mehta Vimal CEO 6,500 $25.79 $167.6K 1
2023-05-15 Sell Steinhart Richard I CFO 5,000 $27.17 $135.8K 1
2023-05-15 Sell Rodriguez Javier Other officer 1,785 $27.32 $48.8K 1
2023-04-06 Sell Nandabalan Krishnan Director 60,000 $17.32 $1.0M 1
2023-03-21 Sell Mehta Vimal CEO 30,000 $19.71 $591.4K 2
2023-03-20 Sell Mehta Vimal CEO 34,500 $18.32 $631.9K 4
2023-03-15 Sell Steinhart Richard I CFO 2,084 $19.50 $40.6K 1
2023-03-15 Sell Yocca Frank Other C-suite 985 $19.69 $19.4K 1
2023-03-15 Sell Rodriguez Javier Other officer 950 $19.63 $18.6K 1
2023-03-15 Sell O'Neill Vincent Other C-suite 845 $19.70 $16.6K 1
2023-01-20 Sell Yocca Frank Other C-suite 50,000 $30.00 $1.5M 1
2023-01-20 Sell O'Neill Vincent Other C-suite 29,713 $30.00 $891.4K 1
2023-01-05 Sell Nandabalan Krishnan Director 25,889 $22.34 $578.3K 2
2023-01-04 Sell Nandabalan Krishnan Director 34,111 $21.77 $742.5K 2
2022-12-16 Sell Mehta Vimal CEO 30,000 $19.44 $583.3K 2
2022-12-15 Sell Mehta Vimal CEO 30,000 $19.94 $598.2K 2
2022-11-11 Sell Nandabalan Krishnan Director 32,550 $15.00 $488.2K 1
2022-11-10 Sell Nandabalan Krishnan Director 27,450 $15.00 $411.8K 1

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
Mehta Vimal CEO $0 $4.3M 2026-05-20
Nandabalan Krishnan Director $0 $3.3M 2023-04-06
Yocca Frank Other C-suite $0 $1.5M 2026-05-20
O'Neill Vincent Other officer $0 $911.9K 2024-12-16
Steinhart Richard I CFO $0 $191.6K 2026-05-20
Rodriguez Javier Other officer $0 $81.8K 2026-05-20
Wiley Matthew T. Other C-suite $0 $6.6K 2024-10-03

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2019-08-13 → 2019-08-23 3 $188.3K 55 -24.3% (-20.1% raw)-37.5% (-27.1% raw)+244.6% (+246.9% raw) closed
2018-11-29 → 2018-12-14 5 $110.8K 53 +15.7% (+4.8% raw)+60.3% (+58.8% raw)+123.3% (+120.9% raw) closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.